Adetunji Toriola, MD, MPH, PhD

Adetunji_ToriolaAssistant Professor, Division of Public Health Sciences
Department of Surgery
(314) 286-2668

Dr. Toriola trained and worked as a physician and subsequently became interested in public health and cancer prevention. Afterwards, he undertook trainings in public health (MPH), epidemiology (PhD) in Finland, and a postdoctoral fellowship in cancer epidemiology and prevention at the German Cancer Research Center (DKFZ), Heidelberg, Germany. Dr. Toriola is a molecular cancer epidemiologist, whose research focus is on the utility of biomarkers to elucidate the associations of energetics, hormones and inflammation with cancer risk and mortality, particularly ovarian, breast cancers and gastrointestinal cancers. He has taken leading roles in studies conducted within large cohorts such as the Women’s Health Initiative Observational Study, Finnish Maternity Cohort, and Kuopio Ischemic Heart Disease Risk Factor Study.

Selected Publications

  1. Alimujiang A, Imm K, Appleton C, Colditz GA, Berkey CS, Toriola AT. Adiposity at age 10 and mammographic density among premenopausal women. Cancer Prev Res (Phila). 2018 Mar 2. pii: canprevres.0309.2017. doi: 10.1158/1940-6207.CAPR-17-0309. PMID: 29500187.
  2. Toriola AT, Dang HA, Hagermann IS, Appleton CM, Colditz GA, Luo J, Maher CA. Increased breast tissue receptor activator of nuclear factor- kB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women. Oncotarget. 2017 May 17;8(43):73787-73792. doi: 10.18632/oncotarget.17909. eCollection 2017 Sep 26. PMID: 29088745.
  3. Yang L, Toriola AT. Inflammation Modifies the Association of Obesity with Circulating 25-Hydroxyvitamin D Levels in Cancer Survivors. Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S58-S65. doi: 10.1002/oby.22011. PMID: 29086515. 
  4. Toriola AT, Ziegler M, Li Y, Pollak M, Stolzenberg-Solomon R. Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival. Ann Surg Oncol. 2017 Oct;24(11):3212-3219. doi: 10.1245/s10434-017-5988-y. PMID: 28681154.
  5. Rosner B, Eliassen HA, Toriola AT, Chen WY, Hankinson SE, Willet WC, Berkey CS, Colditz GA. Weight and weight changes in early adulthood and later breast cancer risk. Int. J Cancer. 2017 140(9):2003-2014. PMID: 28801763. 
  6. Fortner RT, Schock H, Kaaks R, Lehtinen M, Pukkala E, Lakso HÅ, Tanner M, Kallio R, Joensuu H, Korpela J, Toriola AT, Hallmans G, Grankvist K, Zeleniuch-Jacquotte A, Toniolo P, Lundin E, Surcel HM. Human chorionic gonadotropin does not correlate with risk for maternal breast cancer: results from the Finnish maternity cohort. Cancer Res. 2017;77(1):134-141. PMID: 27784743.
  7. Nywening TM, Wang-Gillam A, Sanford DE, Belt BA, Panni RZ, Cusworth BM, Toriola AT, Nieman RK, Worley LA, Yano M, Fowler KJ, Lockhart AC, Suresh R, Tan BR, Lim KH, Fields RC, Strasberg SM, Hawkins WG, DeNardo DG, Goedegebuure SP, Linehan D. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol. 2016;17(5):651-62. doi: 10.1016/S1470-2045(16)00078-4. PMID: 27055731.
  8. Morrison L, Laukkanen JA, Ronkainen K, Kurl S, Kauhanen J, Toriola AT. Inflammatory biomarker score and cancer: A population-based prospective cohort study. BMC Cancer 2016: 10;16:80. doi: 10.1186/s12885-016-2115-6. PMID: 26860264.
  9. Toriola AT, Liu J, Ganz PA, Colditz GA, Yang L, Izadi S, Naughton MJ, Schwartz AL, Wolin KY. Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors. Breast Cancer Res Treat. 2015;152(3):637-43. PMID: 26175059. PMCID: PMC4521978.
  10. Toriola AT, Nguyen N, Scheitler-Ring K, Colditz G. Circulating 25-hydroxyvitamin D (25-OHD) levels and prognosis among cancer patients: a systematic review. Cancer Epidemiol Biomark Prev. 2014:23(6); 917-933. PMID: 24692501. 
  11. Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G. Diabetes and pancreatic cancer survival: a prospective cohort-based study. Br J Cancer 2014:111(1): 181-5. 
  12. Toriola AT, Laukannen JA, Kurl S, Nyyssonen K, Ronkainen K, Kauhanen J. Pre-diagnostic circulating markers of inflammation and risk of prostate cancer. International Journal of Cancer 2013:133 (12); 2961-7.
  13. Toriola AT, Cheng T-YD, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SAA, Gunter MJ, Caudill MA, Ulrich CM. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 2013:132(11):2648-59. PMID: 23161620.
  14. Toriola AT, Grankvist K, Agborsangaya C, Lukanova A, Lehtinen M, Surcel HM. Changes in C-reactive protein concentrations and the risk of ovarian cancer: a longitudinal study. Ann Oncol 2011; 22(8): 1916-1921. PMID: 21292643.
  15. Toriola AT, Lundin E, Lehtinen M, Grankvist K, Pukkala E, Chen T, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Surcel HM, Lukanova A. Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomark Prev 2011;20(8):1798-1801. PMID: 21680537 PMCID: PMC3153607.

Dr. Toriola on PubMed.